Jinfang Song
Jiangsu Key Laboratory Of New Drug Research And Clinical Pharmacy
Xuzhou, China
Xuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Reduction in Albuminuria with Dapagliflozin Exhibits Substantial Interindividual Variability: A Real-World Study Utilizing a Big Data Approach.
Journal: Balkan medical journal
Published: April 02, 2026
GSK3B variations influence renoprotective responses to dapagliflozin in diabetic kidney disease.
Journal: iScience
Published: November 12, 2025
Combined serum neurofilament light chain and Tau as biomarkers of diabetic peripheral neuropathy.
Journal: Frontiers in endocrinology
Published: September 24, 2025
Predictive serum metabolic markers in GDM patients: A targeted metabolomics study combined with machine learning of sex steroid hormones.
Journal: Journal of pharmaceutical analysis
Published: July 25, 2025
Case-control study combined with machine learning techniques to identify key genetic variations in GSK3B that affect susceptibility to diabetic kidney diseases.
Journal: BMC endocrine disorders
Published: November 21, 2024
Prrx1 promotes mesangial cell proliferation and kidney fibrosis through YAP in diabetic nephropathy.
Prrx1 promotes mesangial cell proliferation and kidney fibrosis through YAP in diabetic nephropathy.
Journal: Journal of pharmaceutical analysis
Published: November 07, 2024
Predictive factors of response to liraglutide in patients with type 2 diabetes mellitus and metabolic syndrome.
Journal: Frontiers in endocrinology
Published: June 15, 2024
Establishment of an Integrated Population Pharmacokinetic/ Pharmacodynamics Model of Apixaban in Chinese Healthy Population Adjusting for Key Genetic Variants.
Journal: Current pharmaceutical design
Published: February 21, 2024
Unraveling genetic causality between metformin and myocardial infarction on the basis of Mendelian randomization.
Journal: Frontiers in endocrinology
Published: January 25, 2024
17β-Estradiol, through activating the G protein-coupled estrogen receptor, exacerbates the complication of benign prostatic hyperplasia in type 2 diabetes mellitus patients by inducing prostate proliferation.
Journal: Journal of pharmaceutical analysis
Published: December 11, 2023
Evaluation of the effectiveness regarding the participation of pharmacists in perioperative blood glucose management via the iGMS: a pilot RCT.
Journal: Diabetology & metabolic syndrome
Published: September 10, 2023
Last Updated: 09/26/2026